Scientific Name: Clonidine
Brand Name: Catapres, Catapres-TTS, Catapres-tts-1, Duraclon, Kapvay
Company Owner: Boehringer ingelheim, Aveva drug delivery systems inc, Mylan technologies inc, Tris pharma inc, Pharmaforce inc, Bioniche pharma usa llc, Actavis elizabeth llc, American therapeutics inc, Dava pharmaceuticals inc, Duramed pharmaceuticals inc sub barr laboratories inc, Impax laboratories inc, Interpharm inc, Mutual pharmaceutical co inc, Mylan pharmaceuticals inc, Par pharmaceutical inc, Sandoz inc, Teva pharmaceuticals usa inc, Unichem laboratories ltd, Vintage pharmaceuticals llc, Warner chilcott div warner lambert co, Watson laboratories inc, Shionogi pharma inc
Mechanism Of Action Clonidine is primarily an alpha-2 adrenoceptor agonist which causes central hypotensive and anti-arrhythmogenic effects.
Description of the Drug: Clonidine is an alpha-2 adrenergic agonist used to treat hypertension and severe cancer pain, among other conditions, and to treat withdrawal symptoms from various substances. It is also used to aid in the diagnosis of pheochromocytoma and to prevent migraines.
Protein Data Bank:
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00575